Biblio
Anti-apoptotic molecule BCL2 is a therapeutic target in steroid-refractory graft-versus-host disease. J Invest Dermatol. 2020.
Antigen-Specific Immunoadsorption With the Glycosorb® ABO Immunoadsorption System as a Novel Treatment Modality in Pure Red Cell Aplasia Following Major and Bidirectional ABO-Incompatible Allogeneic Hematopoietic Stem Cell Transplantation. Front Med (Lausanne). 2020;7:585628.
Correction to: Platelet number and graft function predict intensive care survival in allogeneic stem cell transplantation patients. Ann Hematol. 2018.
. Emergency department utilization following allogeneic hematopoietic stem cell transplantation: a single-center retrospective longitudinal analysis of 557 patients. Transplant Cell Ther. 2023.
. Extracorporeal membrane oxygenation in adults receiving haematopoietic cell transplantation: an international expert statement. Lancet Respir Med. 2023.
Impact of chronic graft-versus-host-disease on intensive care outcome in allogeneic hematopoietic stem cell recipients. Bone Marrow Transplant. 2022.